Brain Fog & Hyperbaric Oxygen by Dr Paul Harch, MD скачать в хорошем качестве

Brain Fog & Hyperbaric Oxygen by Dr Paul Harch, MD

FOR IMMEDIATE RELEASE L.A. City Films Announces Hollywood Screening & Medical Lecture on Individually Dosed Hyperbaric Oxygen Therapy by Paul G. Harch, M.D. from Harch Hyperbaric, New Orleans. HOLLYWOOD, CA (Feb. 28, 2026) - L.A. City Films announces a special Hollywood screening of Undeniable Evidence: Clean Medicine. Dirty Politics. followed by a 20-minute medical lecture by Paul G. Harch, M.D., Medical Director of Harch Hyperbarics. The event takes place Saturday, February 28, 2026 at 10:00 a.m. at the TCL Chinese Theatre, steps from the Hollywood Walk of Fame. Dr. Harch’s lecture will focus on a central issue in modern hyperbaric oxygen therapy: dose. Hyperbaric oxygen is regulated as a drug, and—like any drug—its outcomes depend on dose, patient response, and clinical oversight. Dr. Harch will present his Patent PendingⓅ approach to qEEG-based hyperbaric oxygen therapy dosing, using qEEG (quantitative electroencephalogram) to help identify how an individual brain responds to different pressure and oxygen levels. “Hyperbaric oxygen is not a guessing game,” said Dr. Harch. “The same protocol given to everyone can produce uneven results. Individualized dosing is the missing step.” A growing problem in the public perception of HBOT is that the therapy is increasingly offered in non-medical and minimally supervised settings, often marketed as simple and universally effective. The reality is more complex. The rapid spread of hyperbaric oxygen into non-medical and minimally supervised settings has contributed to uneven outcomes and, in rare but documented cases, serious safety incidents. These events have damaged public trust in a therapy that, when properly prescribed and medically supervised, operates like any other drug—dependent on dose, patient response, and clinical oversight. When hyperbaric oxygen is delivered without individualized dosing or physician supervision, outcomes become unpredictable—reinforcing the misconception that the therapy itself is unreliable. Dr. Harch has spent decades in hyperbaric medicine and has refined a brain-focused individualized dosing workflow over the last 10 years, integrating qEEG response testing to better match treatment dose to patient physiology. EVENT DETAILS Screening: Undeniable Evidence: Clean Medicine. Dirty Politics. Medical Lecture: “Individually Dosed HBOT Using qEEG (Quantitative EEG)” (Patent PendingⓅ) Date/Time: Saturday, Feb. 28, 2026 — 10:00 a.m. Location: TCL Chinese Theatre, Hollywood, CA FOR PATIENTS & MEDIA INQUIRIES Harch Hyperbarics — (504) 309-4948 More information: HBOT.com